This report discusses the enrollment process for private prescription drug plans (PDPs) or Medicare Advantage prescription drug (MA-PD) plans. At a minimum, these plans offer "standard coverage" or alternative coverage with actuarially equivalent benefits. Beneficiaries are required to enroll in one of these private plans in order to obtain coverage
A letter report issued by the General Accounting Office with an abstract that begins "To protect the...
Correspondence issued by the General Accounting Office with an abstract that begins "Pursuant to a c...
Chapter summary Each year the Commission provides a status report on the Medicare Advantage (MA) pro...
This report discusses the enrollment process for private prescription drug plans (PDPs) or Medicare ...
drug plans (PDPs), encompassing many more options than previously available. The Medicare Part D pro...
Testimony issued by the Government Accountability Office with an abstract that begins "Under the Med...
Since January 2006 Medicare beneficiaries have the option to purchase prescription drug benefits fro...
Chapter summary Each year the Commission provides a status report on Part D to monitor program perfo...
A letter report issued by the Government Accountability Office with an abstract that begins "Since J...
We investigate prescription drug use, and information and enrollment intentions for the new Medicare...
This issue brief provides an overview of Medicare prescription drug plans (PDPs), with a focus on fu...
The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) established a volun...
A letter report issued by the General Accounting Office with an abstract that begins "As Congress co...
Whether you’re going on Medicare for the first time, changing who provides your drug coverage or ch...
If you did not meet the May 15, 2006, deadline for open initial enrollment in Medicare Part D Prescr...
A letter report issued by the General Accounting Office with an abstract that begins "To protect the...
Correspondence issued by the General Accounting Office with an abstract that begins "Pursuant to a c...
Chapter summary Each year the Commission provides a status report on the Medicare Advantage (MA) pro...
This report discusses the enrollment process for private prescription drug plans (PDPs) or Medicare ...
drug plans (PDPs), encompassing many more options than previously available. The Medicare Part D pro...
Testimony issued by the Government Accountability Office with an abstract that begins "Under the Med...
Since January 2006 Medicare beneficiaries have the option to purchase prescription drug benefits fro...
Chapter summary Each year the Commission provides a status report on Part D to monitor program perfo...
A letter report issued by the Government Accountability Office with an abstract that begins "Since J...
We investigate prescription drug use, and information and enrollment intentions for the new Medicare...
This issue brief provides an overview of Medicare prescription drug plans (PDPs), with a focus on fu...
The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) established a volun...
A letter report issued by the General Accounting Office with an abstract that begins "As Congress co...
Whether you’re going on Medicare for the first time, changing who provides your drug coverage or ch...
If you did not meet the May 15, 2006, deadline for open initial enrollment in Medicare Part D Prescr...
A letter report issued by the General Accounting Office with an abstract that begins "To protect the...
Correspondence issued by the General Accounting Office with an abstract that begins "Pursuant to a c...
Chapter summary Each year the Commission provides a status report on the Medicare Advantage (MA) pro...